Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Credo Life Sciences is a pharmaceutical company based in Hyderabad, India, specializing in the development and manufacturing of finished dosage forms. The company operates state-of-the-art facilities dedicated to oral solid dosages, including tablets and capsules, as well as liquid orals. Credo focuses on providing high-quality generic medications across various therapeutic segments such as gastroenterology, cardiology, and metabolic disorders. They offer contract manufacturing and development services (CDMO) to global partners, leveraging their WHO-GMP certified infrastructure. The company is committed to meeting international quality standards to serve both domestic and regulated international markets. Their business model emphasizes the production of affordable healthcare solutions through advanced formulation technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Credo Life Sciences.